Arrhythmias & electrophysiology

2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association

J Am Coll CardiolPublished Clinical performance and quality measures statement

Recommendations

As issued by the authors

  1. Performance measures: patients with newly diagnosed atrial fibrillation (AF) receive a basic clinical evaluation, with emphasis on secondary prevention at all stages of AF, documenting stroke risk and, if indicated, providing appropriate anticoagulation

  2. Quality measures: measuring and addressing health inequities, optimizing antiarrhythmic or anticoagulant treatment, shared decision-making for rate- vs rhythm-control strategies, and, in appropriate patients, offering catheter ablation for HFrEF

Original publication

2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association. J Am Coll Cardiol. Published 17 August 2026. doi:10.1016/j.jacc.2026.05.032

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.